Silent lupus nephritis: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20223672Keywords:
Systemic lupus erythematosus, Nephritis, Renal biopsyAbstract
Systemic lupus erythematosus (SLE) is a multiorgan acquired autoimmune disease. The clinical picture can vary greatly. Lupus nephritis (LN), which affects about 50% of SLE patients, is associated with high morbidity and death. While renal histologic alterations are evident in almost all patients with SLE, clinical renal involvement only affects 40% to 75% of those individuals. Because of this, some patients who have nephritis on their renal biopsy may not actually have clinical kidney disease (silent nephritis). In this article, we discuss a case of silent lupus nephritis (SLN) with respect to clinical presentation, laboratory findings, diagnosis and outcome.
References
Putterman C, Caricchio R, Davidson A, Perlman H. Systemic lupus erythematosus. Clin Dev Immunol. 2012;437282.
Vaillant A, Akpaka EP, Poonking P. Systemic Lupus Erythematosus: some Epidemiological and Clinical Aspects. Am J Public Health Res. 2015;3(2):46-50.
Estel GJ, Quintana R, Alarcón GS, Sacnún M, Gil MF, Estel BA, et al. A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients. Lupus. 2018;27(10):1753-4.
Lewis MJ, Jawad AS. The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology (Oxford). 2017;56(1):67-77.
Maidhof W, Hilas O. Lupus: an overview of the disease and management options. Pharm Therap. 2012;37(4):240.
Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825-35.
El-Sayed KM, Mohamed EA, Rashed ASM, El-Aziz Shehata MSA, Mandour EMR, et al. Renal histopathological profile in patients with silent lupus nephritis. Al-Azhar Medl J. 2021;50.
Xu S, Liu Z, Chen H, Zeng C, Zhang H, Hu W. Diffuse segmental and pure diffuse global proliferative glomerulonephritis: different patterns of class IV lupus nephritis. Clin Nephrol. 2014;81(6):411-8.
Baldwin DS, Lowenstein J, Rothfield NF, Gallo G, McCluskey RT, et al. The clinical course of the proliferative and membranous forms of lupus nephritis. Ann Intern Med. 1970;73:929-42.
Hsieh SC, Tsai CY, Yu CL. Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems. Open Access Rheumatol. 2016;8:81-91.
Chen CY, Chen YH, Lin HC, Chen SF, Lin HC. Increased risk of adverse pregnancy outcomes for hospitalisation of women with lupus during pregnancy: a nationwide population-based study. Clin Exp Rheumatol-Including Suppl. 2010;28(1):49.
Wagner SJ, Craici I, Reed D, Norby S, Bailey K, Wiste HJ, et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus. 2009;18(4):342-7.
Gouda W, Abd Elaziz Alsaid A, Abbas AS, Abdel-Aziz TM, Shoaeir MZ, Abd Elazem AAS, Sayed MH. Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1. Open Access Rheumatol. 2022;14:161-70.
El-Sayed KM, Mohamed EA, Rashed AM, Shehata MSAE, Mandour EMR. Renal histopathological profile in patients with silent lupus nephritis. Al-Azhar Med J (Medicine). 2021;50(2):1281-92.
Rahman FZ, Rahman J, Al-Suleiman SA, Rahman MS. Pregnancy outcome in lupus nephropathy. Arch Gynecol Obstet. 2005;271(3):222-6.
